GU Cancers 2020 | Chemo eligibility: bladder cancer

Name: Chemo eligibility: bladder cancer
Uploaded: 2020-02-16T02:16:53Z
Description: Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses whether it is necessary to redefine cisplatin-ineligibility in metastatic urothelial cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Srikala Sridhar • 16 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer Carboplatin Cisplatin

Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses whether it is necessary to redefine cisplatin-ineligibility in metastatic urothelial cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.